80 nationalities volunteer to participate in vaccine trials
Gulf Today|August 07, 2020
80 nationalities volunteer to participate in vaccine trials
Our trials are moving faster than others in the world, thanks to the winning combination of a national spirit of volunteerism and strength of the UAE’s healthcare system, says official

The world’s first Phase III trials of an inactivated vaccine for COVID-19 being held in the United Arab Emirates have reached a major milestone with over 5000 volunteers having now received their first vaccination.

The 5000th vaccination was given in the presence of Dr Jamal Al Kaabi, the Acting Under-Secretary of Department of Health, Abu Dhabi, at the recently developed purpose-built walk-in registration, screening and testing centre at the Abu Dhabi National Exhibition Centre (ADNEC).

Dr Al Kaabi was the second participant in the vaccination programme and received his second shot this week.

The trials began in Abu Dhabi on July 16 and are being managed by G42 Healthcare in partnership with the Department of Health - Abu Dhabi, the UAE Ministry of Health and Prevention (MoHAP), and Abu Dhabi Health Services Company (SEHA).

The inactivated vaccine has been developed by Sinopharm CNBG, the world’s sixth-largest vaccine manufacturer.

A sense of nationwide pride and shared commitment has led to over 80 nationalities in the community already volunteering to participate, inspired by the UAE Leadership’s commitment to overcoming the pandemic through a global collaborative effort.


You can read up to 3 premium stories before you subscribe to Magzter GOLD

Log in, if you are already a subscriber


Get unlimited access to thousands of curated premium stories, newspapers and 5,000+ magazines


August 07, 2020